Locally Advanced Urothelial Cancer

DrugDrug NameDrug Description
DB13007Enfortumab vedotinAn antibody-drug conjugate comprised of a fully human monoclonal antibody and microtubule-disrupting chemotherapeutic agent used in the treatment of advanced or metastatic urothelial cancer.
DrugDrug NamePhaseStatusCount
DB15766Retifanlimab2Active Not Recruiting1
DB01248Docetaxel3Not Yet Recruiting1
DB01229Paclitaxel3Not Yet Recruiting1
DB12893Sacituzumab govitecan3Not Yet Recruiting1
DB11641Vinflunine3Not Yet Recruiting1